LexisNexis® Legal Newsroom
Amylin Sues Eli Lilly Over Diabetes Drug Development Deal

INDIANAPOLIS - (AP) Amylin Pharmaceuticals Inc. said Monday it filed a lawsuit against Eli Lilly and Co., accusing the larger drugmaker of breaking their commercialization deal for diabetes drugs by teaming with the German company Boehringer Ingelheim to develop and sell a competing product. Amylin,...

Lawsuits Follow Diabetes Drug Actos' Link To Cancer Risk

TRENTON, N.J. - (AP) The maker of the world's best-selling diabetes drug is facing hundreds of lawsuits and likely a big sales drop as suspicion grows that taking the pill for more than a year raises the risk of bladder cancer. In June, Takeda Pharmaceuticals Co. Ltd. halted sales of Actos. . . ...

Maryland Jury Awards $1.7 Million In 2nd Actos Bladder Cancer Case

BALTIMORE — (Mealey’s) A Maryland state court jury on Sept. 26 awarded $1.76 million in the second Actos bladder cancer case to go to trial ( An v. Takeda Pharmaceuticals America, Inc. , No. 24-C12003565, Md. Cir., Baltimore City). ( Verdict sheet available. Document #28-131003-013V ....